Skip to main content

Michael Pollack, MS

Director, US Payer Evidence
Respiratory and Immunology Franchise Lead,
AstraZeneca
Wilmington, DE

Mr Pollack is Director, US Payer Evidence, Respiratory and Immunology Franchise Lead, AstraZeneca, Wilmington, DE.

Authored Items
The Quality of Care and Economic Burden of COPD in the United States: Considerations for Managing Patients and Improving Outcomes
David L. Larsen, RN, MHA, Hitesh Gandhi, MBBS, Michael Pollack, MS, Norbert Feigler, MD, Sushma Patel, PharmD, Robert A. Wise, MD
June 2022 Vol 15, No 2 in Clinical, Review Article
Last modified: June 23, 2022